Jens Kastrup

Medicin og biovidenskab

1. Coronary Artery Disease 100%
2. Mesenchymal Stem Cells 99%
3. Myocardial Ischemia 73%
4. Stromal Cells 68%
5. Myocardial Infarction 63%
6. Cell- and Tissue-Based Therapy 61%
7. Stem Cells 53%
8. Placebos 53%
9. ST Elevation Myocardial Infarction 47%
10. Coronary Disease 42%
11. Mortality 37%
12. Granulocyte Colony-Stimulating Factor 36%
13. Heart Failure 34%
14. Angina Pectoris 33%
15. Clarithromycin 31%
16. Biomarkers 31%
17. Perfusion 30%
18. Vascular Endothelial Growth Factor A 29%
19. Positron-Emission Tomography 27%
20. Stroke Volume 27%
21. Injections 26%
22. Therapeutics 26%
23. Bone Marrow 24%
24. Adipose Tissue 22%
25. Percutaneous Coronary Intervention 22%
26. Serum 22%
27. Leg 20%
28. Hematopoietic Stem Cell Mobilization 20%
29. Ischemia 20%
30. Rubidium-82 18%
31. Magnetic Resonance Imaging 18%
32. Electrocardiography 18%
33. Heart 17%
34. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 17%
35. Safety 17%
36. Bone Marrow Cells 16%
37. Myocardium 16%
38. Left Ventricular Function 16%
39. Echocardiography 15%
40. Insulin 15%
41. Arterial Pressure 14%
42. Regeneration 14%
43. Hydroxymethylglutaryl-CoA Reductase Inhibitors 14%
44. Skin 14%
45. Magnetic Resonance Spectroscopy 14%
46. Clinical Trials 13%
47. Doppler Echocardiography 13%
48. Cardiology 13%
49. Coronary Vessels 13%
50. Miniature Swine 12%